PIK3CA and neoplasm: Colorectal cancers with PIK3CA mutations exhibited higher total tumor mutation burdens (TMBs) compared to their unmutated counterparts, highlighting the frequent presence of PIK3CA gene mutations and suggesting potential for developing combination targeted therapies24.